Desktop Site |
11 Jul 25 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 82,500.47 -689.81 -0.83 %
Corporate Announcement
  • Security Code524804
    CompanyAurobindo Pharma Ltd
    Exchange Received Time02/07/2025 16:54:15
    Exchange Disseminated Time02/07/2025 16:54:15
    Time Taken00:00:00
     
     
     Curateq Biologics Receives Marketing Approval For Trastuzumab Biosimilar Dazublys™ From European Commission | 07/02/25 16:54 
     Intimation of receipt of marketing approval for trastuzumab biosimilar Dazublys from European Commission by Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(42) 12 Jul 25|13:36 (IST)